Profile | GDS4284 / 221030_s_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 4119.29 | 92 |
GSM687648 | Patient 402 control | 2663.46 | 87 |
GSM687653 | Patient 403 control | 3290.63 | 90 |
GSM687658 | Patient 404 control | 1336.92 | 78 |
GSM687663 | Patient 411 control | 4560.05 | 93 |
GSM687668 | Patient 422 control | 3192 | 89 |
GSM687673 | Patient 424 control | 2758.5 | 88 |
GSM687678 | Patient 425 control | 4042.23 | 92 |
GSM687683 | Patient 427 control | 2492.04 | 87 |
GSM687688 | Patient 428 control | 4358.27 | 92 |
GSM687695 | Patient 441 control | 623.096 | 66 |
GSM687699 | Patient 443 control | 2726.21 | 88 |
GSM687704 | Patient 444 control | 2070.13 | 84 |
GSM687707 | Patient 448 control | 2251.58 | 86 |
GSM687712 | Patient 449 control | 2805.31 | 88 |
GSM687719 | Patient 450 control | 2248.66 | 85 |
GSM687724 | Patient 451 control | 5502.18 | 94 |
GSM687728 | Patient 452 control | 3190.6 | 89 |
GSM687646 | Patient 401 treated 24h | 3349.07 | 90 |
GSM687649 | Patient 402 treated 24h | 2346.03 | 86 |
GSM687665 | Patient 411 treated 24h | 4614.2 | 93 |
GSM687651 | Patient 402 treated 4 weeks | 2680.04 | 88 |
GSM687667 | Patient 411 treated 4 weeks | 4946.09 | 93 |
GSM687670 | Patient 422 treated 24h | 1867.23 | 83 |
GSM687671 | Patient 422 treated 4 weeks | 2698.37 | 87 |
GSM687654 | Patient 403 treated 24h | 3467.86 | 90 |
GSM687675 | Patient 424 treated 24h | 2098.71 | 85 |
GSM687685 | Patient 427 treated 24h | 3713.32 | 91 |
GSM687656 | Patient 403 treated 4 weeks | 3025.4 | 89 |
GSM687677 | Patient 424 treated 4 weeks | 3000.96 | 89 |
GSM687687 | Patient 427 treated 4 weeks | 2825.01 | 88 |
GSM687692 | Patient 428 treated 4h | 4412.34 | 92 |
GSM687716 | Patient 449 treated 4h | 1985.62 | 84 |
GSM687722 | Patient 450 treated 4h | 2896.15 | 89 |
GSM687680 | Patient 425 treated 24h | 4733.88 | 93 |
GSM687690 | Patient 428 treated 24h | 4583.36 | 92 |
GSM687700 | Patient 443 treated 24h | 3127.96 | 90 |
GSM687705 | Patient 444 treated 24h | 2411.28 | 86 |
GSM687714 | Patient 449 treated 24h | 2582.34 | 87 |
GSM687721 | Patient 450 treated 24h | 2396.54 | 87 |
GSM687682 | Patient 425 treated 4 weeks | 4991.36 | 93 |
GSM687694 | Patient 428 treated 4 weeks | 4325.01 | 92 |
GSM687702 | Patient 443 treated 4 weeks | 3469.75 | 90 |
GSM687718 | Patient 449 treated 4 weeks | 2104.9 | 85 |
GSM687723 | Patient 450 treated 4 weeks | 3117.31 | 89 |
GSM687661 | Patient 404 treated 4h | 1004.59 | 74 |
GSM687710 | Patient 448 treated 4h | 2353.67 | 86 |
GSM687726 | Patient 451 treated 4h | 3640.25 | 91 |
GSM687730 | Patient 452 treated 4h | 1796.55 | 84 |
GSM687660 | Patient 404 treated 24h | 1274.49 | 80 |
GSM687697 | Patient 441 treated 24h | 912.299 | 73 |
GSM687709 | Patient 448 treated 24h | 2149.18 | 85 |
GSM687725 | Patient 451 treated 24h | 3707.75 | 91 |
GSM687729 | Patient 452 treated 24h | 2062.68 | 86 |
GSM687727 | Patient 451 treated 4 weeks | 5380.58 | 94 |
GSM687731 | Patient 452 treated 4 weeks | 3008.57 | 89 |